Skip to Content

DMTs During Pregnancy in Women with MS Do Not Affect Relapse Rates in Postpartum Periods

In this MEDtalk, Lene von Kappelgaard answers the question, does disease-modifying therapy during pregnancy affect the relapse rate in the postpartum period in women with MS? At ECTRIMS 2024, she presents her study aimed at exploring whether using DMTs during pregnancy affects postpartum relapse rates, especially those receiving fertility treatments, compared to pre-pregnancy or pregnancy periods.

Lene Von Kappelgaard

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top